Permanently Discontinued

RANITIDINE INJECTION USP

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is RANITIDINE INJECTION USP discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that RANITIDINE INJECTION USP 50MG has been permanently discontinued (last updated November 3, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is RANITIDINE INJECTION USP not available?

The reason the manufacturer reported: Manufacturing issues.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusPermanently Discontinued

Same-ingredient products on file3 products · 0 same form & route

Affected strength50MG

Report last updated2020-11-03

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

MINT-RANITIDINE

MINT PHARMACEUTICALS INC

150MG · DIN 02526379

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

MAR-RANITIDINE

MARCAN PHARMACEUTICALS INC

150MG · DIN 02443708

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION

PHARMASCIENCE INC

150MG · DIN 02293471

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02256711

Strength

50MG

Dosage Form

SOLUTION

Route

INTRAMUSCULAR INTRAVENOUS

Active Ingredient

RANITIDINE

Tier

Unrated

Last Updated

2020-11-03

Reason for Shortage

Manufacturing issues

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

RANITIDINE INJECTION USP has 2 shortage/discontinuation reports on file — this is one of them.

2020-11-03

Permanently Discontinued

Manufacturing issues

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929